Role of aryl hydrocarbon receptor in central nervous system tumors: Biological and therapeutic implications

Area of Science:

• Molecular Biology
• Neuro-oncology
• Pharmacology

Background:

• The aryl hydrocarbon receptor (AhR) is a transcription factor regulating xenobiotic metabolism and non-canonical cellular responses like proliferation and differentiation.
• AhR signaling is implicated in central nervous system (CNS) tumors, with polymorphisms in the *AHR* gene linked to glioma development.

Purpose of the Study:

• To investigate the role of the aryl hydrocarbon receptor (AhR) pathway in the development and potential treatment of central nervous system tumors.
• To explore how AhR activation by metabolites influences tumor cell behavior and to assess its therapeutic potential.

Main Methods:

• Review of existing literature on AhR function, polymorphisms, and its role in various CNS tumors.
• Analysis of AhR's involvement in cellular processes such as proliferation, differentiation, cell cycle arrest, and apoptosis within tumor contexts.
• Examination of AhR's interaction with tumor metabolism, including tryptophan synthesis and kynurenine activation.

Main Results:

• AhR activation by metabolites like kynurenine promotes proliferation in astrocytomas, medulloblastomas, and glioblastomas.
• In neuroblastomas, AhR downregulates c-Myc, induces differentiation, and triggers cell cycle arrest and apoptosis.
• *AHR* gene polymorphisms are associated with glioma development.

Conclusions:

• The aryl hydrocarbon receptor (AhR) pathway plays a significant role in regulating tumor growth and cellular responses in CNS tumors.
• Modulating the AhR pathway presents a promising novel strategy for the treatment of specific tumor types by controlling tumor progression.